OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Roles of lipid metabolism and its regulatory mechanism in idiopathic pulmonary fibrosis: A review
Yunchuan Tian, Chunyan Duan, Jia-Yue Feng, et al.
The International Journal of Biochemistry & Cell Biology (2022) Vol. 155, pp. 106361-106361
Closed Access | Times Cited: 15
Yunchuan Tian, Chunyan Duan, Jia-Yue Feng, et al.
The International Journal of Biochemistry & Cell Biology (2022) Vol. 155, pp. 106361-106361
Closed Access | Times Cited: 15
Showing 15 citing articles:
Dysregulation of metabolic pathways in pulmonary fibrosis
Rishi Rajesh, Reham Atallah, Thomas Bärnthaler
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108436-108436
Open Access | Times Cited: 47
Rishi Rajesh, Reham Atallah, Thomas Bärnthaler
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108436-108436
Open Access | Times Cited: 47
Lipids and lipid metabolism in cellular senescence: Emerging targets for age-related diseases
Qing Zeng, Yongzhen Gong, Neng Zhu, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102294-102294
Closed Access | Times Cited: 30
Qing Zeng, Yongzhen Gong, Neng Zhu, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102294-102294
Closed Access | Times Cited: 30
Identification of glycolysis-related gene signatures for prognosis and therapeutic targeting in idiopathic pulmonary fibrosis
Han Gao, Zhongyi Sun, Xingxing Hu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Han Gao, Zhongyi Sun, Xingxing Hu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Cordyceps sinensis ameliorates idiopathic pulmonary fibrosis in mice via inhibiting mitochondrion‐mediated oxidative stress
Ying Zhang, Lirun Zhou, Guangqing Cheng, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 4
Ying Zhang, Lirun Zhou, Guangqing Cheng, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 4
Fatty acids metabolism in ozone-induced pulmonary inflammatory injury: Evidence, mechanism and prevention
Mengyuan Li, Xiangbing Kong, Xiaotong Jian, et al.
The Science of The Total Environment (2024) Vol. 933, pp. 173222-173222
Closed Access | Times Cited: 2
Mengyuan Li, Xiangbing Kong, Xiaotong Jian, et al.
The Science of The Total Environment (2024) Vol. 933, pp. 173222-173222
Closed Access | Times Cited: 2
Identifying a survival-associated cell type based on multi-level transcriptome analysis in idiopathic pulmonary fibrosis
Fei Xu, Yun Tong, Wenjun Yang, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Fei Xu, Yun Tong, Wenjun Yang, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Identification and validation of potential biomarkers related to oxidative stress in idiopathic pulmonary fibrosis
Xianglin L. Du, Zhen Ma, Y. Xing, et al.
Immunobiology (2024) Vol. 229, Iss. 5, pp. 152791-152791
Open Access
Xianglin L. Du, Zhen Ma, Y. Xing, et al.
Immunobiology (2024) Vol. 229, Iss. 5, pp. 152791-152791
Open Access
Genetic association of lipids and lipid-lowering drug target genes with sarcoidosis
Wei Tan, Zicheng Liang, Yu Liu, et al.
Research Square (Research Square) (2024)
Open Access
Wei Tan, Zicheng Liang, Yu Liu, et al.
Research Square (Research Square) (2024)
Open Access
Changes in PI3K/AKT and NRF2/HO-1 signaling expression and intestinal microbiota in bleomycin-induced pulmonary fibrosis
Chenchen Li, Yuxia Cao, Yousheng Peng, et al.
Food and Chemical Toxicology (2024) Vol. 190, pp. 114796-114796
Closed Access
Chenchen Li, Yuxia Cao, Yousheng Peng, et al.
Food and Chemical Toxicology (2024) Vol. 190, pp. 114796-114796
Closed Access
Sirtuin3 and Sirtuin7 are promising biomarkers in systemic sclerosis
Yasmine S. Makarem, Nihal Fathi, Mai H. El-Morabaa, et al.
Egyptian Rheumatology and Rehabilitation (2024) Vol. 51, Iss. 1
Open Access
Yasmine S. Makarem, Nihal Fathi, Mai H. El-Morabaa, et al.
Egyptian Rheumatology and Rehabilitation (2024) Vol. 51, Iss. 1
Open Access
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Gexiang Cai, Jingjing Liu, Mengsi Cai, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access
Gexiang Cai, Jingjing Liu, Mengsi Cai, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access
Genetic association of lipids and lipid lowering drug target genes with sarcoidosis
Wei Tan, Zicheng Liang, Yu Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Wei Tan, Zicheng Liang, Yu Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Regulating Lipid Metabolism in Gout: A New Perspective with Therapeutic Potential
Xianheng Zhang, Jian Liu
International Journal of General Medicine (2024) Vol. Volume 17, pp. 5203-5217
Open Access
Xianheng Zhang, Jian Liu
International Journal of General Medicine (2024) Vol. Volume 17, pp. 5203-5217
Open Access
The potential lipid biomarker 5‐HETE for acute exacerbation identified by metabolomics in patients with idiopathic pulmonary fibrosis
Yichao Zhao, Yanchen Shi, Ji Zhang, et al.
Respirology (2024)
Closed Access
Yichao Zhao, Yanchen Shi, Ji Zhang, et al.
Respirology (2024)
Closed Access
Untargeted Metabolomics Reveals Alterations of Rhythmic Pulmonary Metabolism in IPF
Wei Sun, Jiuqiang Ren, Zixian Jia, et al.
Metabolites (2023) Vol. 13, Iss. 10, pp. 1069-1069
Open Access | Times Cited: 1
Wei Sun, Jiuqiang Ren, Zixian Jia, et al.
Metabolites (2023) Vol. 13, Iss. 10, pp. 1069-1069
Open Access | Times Cited: 1
